1. Redox Control of Multidrug Resistance and Its Possible Modulation by Antioxidants.
   Aysegul Cort et al, 2016, Oxid Med Cell Longev CrossRef
2. Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas
   Peeter Karihtala et al, 2017, Oxidative Medicine and Cellular Longevity CrossRef
3. Copper–zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma
   Kelley Salem et al, 2015, Redox Biology CrossRef
4. Efficacy study of CyberKnife stereotactic radiosurgery combined with CIK cell immunotherapy for advanced refractory lung cancer
   YUAN-YUAN WANG et al, 2013 CrossRef
5. Multi-drug resistance in a canine lymphoid cell line due to increased P-glycoprotein expression, a potential model for drug-resistant canine lymphoma
   M. Zandvliet et al, 2014, Toxicology in Vitro CrossRef
6. Clinical efficacy of CyberKnife combined with chemotherapy and hyperthermia for advanced non-small cell lung cancer
   YUAN-YUAN WANG et al, 2013 CrossRef
7. Non-Hodgkin’s B-cell lymphoma: Advances in molecular strategies targeting drug resistance
   Steve A Maxwell et al, 2013, Exp Biol Med (Maywood) CrossRef
8. Mitochondrial Adaptations to Oxidative Stress Confer Resistance to Apoptosis in Lymphoma Cells
   Sarah T. Wilkinson et al, 2012, IJMS CrossRef
9. In vitro antineoplastic effects of auranofin in canine lymphoma cells
   Hong Zhang et al, 2018, BMC Cancer CrossRef
10. The copper chelator ATN-224 induces peroxynitrite-dependent cell death in hematological malignancies
    Kristy Lee et al, 2013, Free Radical Biology and Medicine CrossRef
11. Mitochondrial dysfunction: a neglected component of skin diseases
    René G. Feichtinger et al, 2014, Exp Dermatol CrossRef
12. Mitochondria and redox homoeostasis as chemotherapeutic targets
    Margaret M. Briehl et al, 2014, Biochm. Soc. Trans. CrossRef
13. Expression of Cell-Surface Marker ABCB5 Causes Characteristic Modifications of Glucose, Amino Acid and Phospholipid Metabolism in the G3361 Melanoma-Initiating Cell Line
    Norbert W. Lutz et al, 2016, PLoS ONE CrossRef
14. Chronic Oxidative Stress Increases Resistance to Doxorubicin-Induced Cytotoxicity in Renal Carcinoma Cells Potentially Through Epigenetic Mechanism
    Logeswari Ponnusamy et al, 2016, Mol Pharmacol CrossRef
15. An Automatable Hydrogel Culture Platform for Evaluating Efficacy of Antibody‐Based Therapeutics in Overcoming Chemoresistance
    Anna Kletzmayr et al, 2020, Biotechnol. J. CrossRef
16. NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An Overview
    Alvinsyah Adhityo Pramono et al, 2020, Biomolecules CrossRef
17. Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells
    Wei-Qun Lu et al, 2017, Oncotarget CrossRef
18. PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells
    Boyun Kim et al, 2017, Oncotarget CrossRef
19. Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma
    Renata Colla et al, 2016, Oncotarget CrossRef
20. Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models
    Giovanna Bianchi et al, 2015, Oncotarget CrossRef
21. Stalling the Engine of Resistance: Targeting Cancer Metabolism to Overcome Therapeutic Resistance
    Ethan B. Butler et al, 2013, Cancer Res CrossRef
22. The E3 Ubiquitin Ligase NEDD4-1 Mediates Temozolomide-Resistant Glioblastoma through PTEN Attenuation and Redox Imbalance in Nrf2–HO-1 Axis
    Hao-Yu Chuang et al, 2021, IJMS CrossRef
23. null
    Geise Ellen Broto et al, 2021 CrossRef
24. Review of various NAMPT inhibitors for the treatment of cancer
    Yichen Wei et al, 2022, Front. Pharmacol. CrossRef
25. null
    Geise Ellen Broto et al, 2022 CrossRef